YK-11
A Comprehensive Guide to YK-11
YK-11 is a compound with myostatin inhibitory properties and SARM-like effects, under investigation for its potential to accelerate muscle-building and strength gains.
We cover emerging biohacking topics because our readers ask about them. This is not guidance to self-experiment. This article is educational and not intended to diagnose, treat, or suggest any specific intervention, and should not replace qualified medical advice.
We recognize growing interest in biohacking and experimental-stage substances. This article discusses an experimental method that may not be suitable for DIY use; any consideration belongs with qualified supervision.
Yohimbine
YK-11
Turkesterone
Thymosin Beta-4
Senolytics
Rapamycin
RAD140: Testolone
Plasmalogens
Peptide Therapy
MK-2866: Ostarine
NSC-631570
NAD+ Precursors
Myostatin Pathway / Myostatin Inhibitors
MOTS-c
IGF-1: Insulin-Like Growth Factor 1
GlyNAC: Glycine and NAC
GHK-Cu: Copper Peptide
MK-677 / Ibutamoren: GH Secretagogues
GDF-11
Ecdysterone
BPC-157
Apigenin
S4: Andarine
AKG: Alpha-Ketoglutarate
7-Keto DHEA
YK-11: FACTS
Role | Muscle growth, potential myostatin inhibitor |
Form & Classification | SARM (selective androgen receptor modulator) |
Research Status | Experimental; limited animal and cell data; no human trials |
Sources | Research chemical only, not approved for clinical use |
Risk Profile & Monitoring | Unknown long-term safety, may suppress natural hormones |
Why Is YK-11 Gaining Attention?
YK-11 is gaining attention because it acts as a selective androgen receptor modulator (SARM) and may inhibit myostatin, a protein that limits muscle growth.
YK-11 is gaining attention due to its classification as a selective androgen receptor modulator (SARM) with unique properties. Unlike many SARMs, it also influences myostatin, a protein that limits muscle growth, making it appealing in muscle research. This dual action has sparked curiosity in bodybuilding and medical fields alike. Although early research is limited, the combination of muscle enhancement potential and new biological pathways keeps interest high. Its experimental nature also drives debates around safety and regulation.
YK-11’s myostatin inhibition sets it apart from other SARMs, drawing strong interest for muscle development.
Researchers are intrigued by its potential to increase strength through both androgen signaling and myostatin suppression.
It is followed closely in experimental settings where alternatives to traditional anabolic approaches are explored.
The lack of long-term safety data fuels both caution and curiosity about its potential applications.
What Is YK-11?
YK-11 is a synthetic compound thought to act as a selective androgen receptor modulator (SARM), promoting muscle growth through myostatin inhibition.
YK-11 is a synthetic compound classified as a selective androgen receptor modulator (SARM). It is unique because it may also suppress myostatin, a protein that limits muscle growth. Research in humans is extremely limited, and most data comes from cell and animal studies. Potential risks include hormone imbalance, liver toxicity, and unknown long-term effects. Because it has not gone through clinical testing, its safety profile is uncertain.
YK-11 binds to androgen receptors, influencing muscle development pathways.
Its ability to inhibit myostatin is based mostly on lab studies, not human trials.
Reports suggest it may suppress natural testosterone, requiring careful monitoring.
No clinical data exists on long-term health risks or safe dosing.
What Does YK-11 Do?
YK-11 affects muscle development by binding to androgen receptors and suppressing myostatin, the protein that prevents muscle overgrowth.
YK-11 affects muscle growth processes by targeting androgen receptors and influencing myostatin. Myostatin normally limits muscle size, but YK-11 can reduce its activity, opening pathways for more growth. It binds to androgen receptors, which control muscle and bone development. This dual effect makes it notable in muscle biology research. Its impact is mainly studied in experimental lab settings rather than clinical practice.
YK-11 stimulates muscle-building pathways by activating androgen receptors in muscle cells.
It suppresses myostatin, which usually blocks excessive muscle growth.
The combination of these effects may support faster muscle gain than other SARMs.
It influences bone tissue as well, making it relevant for musculoskeletal health research.
How Is YK-11 Used in Biohacking?
YK-11 is used in biohacking to attempt rapid muscle growth through myostatin inhibition, though evidence in humans is limited.
YK-11 is used in biohacking for muscle growth and performance enhancement. Enthusiasts view it as a next-generation muscle agent due to its action on both androgen receptors and myostatin. It is used experimentally by those seeking faster strength or size gains. Biohackers are attracted to its unique dual pathway activation. However, use outside research is highly experimental and carries unknown risks.
YK-11 is seen as a shortcut to muscle development through combined receptor and myostatin activity.
It is often compared with other SARMs but noted for its potentially stronger effects.
Some biohackers test it in muscle-focused regimens despite lack of safety data.
Discussions stress its untested long-term effects, urging caution in non-clinical use.
Descriptions of protocols are provided to explain research methods only. They are not instructions for personal use. Individuals should not adapt or perform study procedures outside approved research settings with qualified supervision.
How Is YK-11 Used in Research Settings?
YK-11 is used in research to investigate muscle growth pathways and the role of myostatin inhibition.
YK-11 is used in research settings mainly as an experimental SARM. It is studied for muscle growth by targeting androgen receptors and inhibiting myostatin. Laboratory tests examine its effect on muscle cell differentiation and protein synthesis. Its potential for treating muscle-wasting disorders is of particular interest. Because of limited data, studies remain at early stages and mostly preclinical.
YK-11 is tested for its dual effect on muscle growth pathways.
Scientists study its role in blocking myostatin, which naturally restricts muscle size.
Its selective action on muscle tissue makes it promising for wasting disease research.
Current evidence is mostly from lab-based and early cellular studies, not long-term human trials.
How Fast Does YK-11 Work?
YK-11 effects may take weeks to appear, as muscle growth requires gradual receptor and protein pathway changes.
YK-11’s effects may take several weeks to become noticeable since it works by influencing muscle growth pathways. Unlike stimulants, it does not act within hours or days. Its impact on muscle size and strength depends on sustained exposure and training stimulus. Initial strength or performance gains may appear after a few weeks of consistent use. Research suggests it is not an immediate-acting compound but rather one requiring longer cycles.
Muscle growth is gradual, with weeks needed to see measurable changes.
Its influence on myostatin may accelerate progress but not provide instant results.
Performance changes are tied closely to exercise intensity and duration of use.
It requires consistent exposure, unlike fast-acting stimulants or metabolism enhancers.
Is YK-11 Safe?
YK-11 risks include liver toxicity, hormone imbalance, and unknown long-term safety since it is poorly studied in humans.
YK-11 carries risks due to its limited research and strong biological effects. Concerns include liver strain, hormonal imbalance, and unknown long-term impacts. Because it acts on androgen receptors, it may disrupt natural hormone production. Early reports suggest potential toxicity at higher exposures. Its untested safety makes risks uncertain and potentially severe.
Liver toxicity risk is a major concern, though long-term studies are lacking.
Hormone disruption may suppress natural testosterone production.
Unknown effects on fertility and reproductive health remain unresolved.
Its experimental status means many side effects are not yet identified.
Small or early studies can overlook important risks, including organ effects and drug–substance interactions. Product quality outside research supply chains is uncertain. Individuals should not conduct at-home trials; participation should occur only within approved research or clinical care.
What Is the Most Common Form of YK-11?
YK-11 is most commonly available as oral capsules or powders.
YK-11 is most commonly found in capsule or powder form in experimental use. It is taken orally for research purposes. Liquid suspensions are also available in some lab settings. Because it is experimental, no standardized medical form exists. Capsules are most often used for ease of measurement.
Oral capsules are common for controlled intake during experiments.
Powdered forms exist but require accurate measuring tools for safety.
Liquid suspensions are sometimes used in research environments.
No approved pharmaceutical form exists due to its experimental status.
What Are Key Ingredients of YK-11?
YK-11 key ingredient is a synthetic steroidal molecule that acts as a selective androgen receptor modulator.
YK-11’s key ingredient is the experimental molecule itself, classified as a selective androgen receptor modulator. Unlike herbal extracts, it is a synthetic compound with no added natural actives. Its structure allows dual action on androgen receptors and myostatin inhibition. Capsules or powders may contain binding agents but these are inactive. The compound alone is responsible for its effects.
The active molecule is YK-11, with both androgen and myostatin activity.
No natural or herbal components are included in its design.
Capsule fillers or stabilizers are present but inactive.
The compound itself drives all biological effects studied in research.
Is YK-11 Naturally Available in Food?
YK-11 is not naturally present in food as it is a synthetic compound.
YK-11 is not naturally available in food. It is a fully synthetic compound created in laboratories. No fruits, vegetables, or animal products contain it. Because it is experimental, it is not part of human nutrition. Its only source is research-based synthesis.
No natural food sources provide YK-11.
It was designed as a synthetic SARM, not derived from plants or animals.
Human diets cannot supply this compound naturally.
Its availability is restricted to lab production.
Does YK-11 Impact Longevity?
YK-11 impact on longevity is not known because safety and long-term effects are unstudied.
YK-11 has no proven effects on longevity. Its focus is muscle growth, not aging processes. Some speculate that preserving muscle may indirectly support lifespan, but no direct evidence exists. Risks like hormone disruption could even reduce long-term health. It is not recognized as a compound that extends lifespan.
No studies connect YK-11 with lifespan or aging improvements.
Its action on muscle growth does not address root causes of aging.
Hormonal risks could shorten healthspan rather than extend it.
It remains studied mainly for anabolic rather than anti-aging purposes.
Does Tolerance Develop for YK-11?
YK-11 tolerance is not documented, but long-term use may alter hormone receptor sensitivity.
YK-11 tolerance development is not well studied due to its experimental nature. Some speculate that androgen receptors may downregulate (reduce responsiveness) over time. This could lower its effectiveness for muscle growth during extended use. Because of unknowns, conservative trial periods are favored. Long-term tolerance risks remain unclear but possible.
No formal studies confirm tolerance development for YK-11.
Theoretical risk exists from receptor downregulation with long exposure.
Prolonged cycles may reduce efficiency in stimulating muscle growth.
Short experimental use with cooldown periods is safer until more is known.
Short, controlled tests do not establish long-term safety or cumulative effects. This information is for context, not for ongoing personal use. Exposure to experimental substances should not occur outside clinically supervised tests.
Do YK-11 Effects Persist?
YK-11 effects may persist partly through muscle gained, but hormone balance returns to normal after discontinuation.
YK-11 effects may persist for weeks during use but fade after discontinuation. Muscle gains achieved during cycles can last if training and diet continue. However, hormonal suppression may cause muscle loss when use stops. Its long-term persistence is uncertain due to lack of studies. Benefits are therefore dependent on ongoing use and lifestyle support.
Muscle growth achieved may remain if maintained by exercise and nutrition.
Stopping use may reverse gains if hormones or training are inadequate.
Hormonal suppression could reduce muscle retention after discontinuation.
No evidence suggests permanent cellular changes beyond muscle mass gained.
Signals that look promising in a lab may not hold up in broader populations and may reveal risks later. This information is explanatory only and does not support self-directed use to “reproduce” results.
How Long Do YK-11’s Side Effects and Traces Persist?
YK-11 side effects and traces may last several days, but long-term hormone disruption risk is unknown.
YK-11 side effects and traces may persist for weeks after discontinuation. Hormonal suppression can take time to normalize. Some risks like liver strain may require recovery periods. Muscle and hormonal imbalances may last longer without intervention. Full clearance depends on individual metabolism and cycle length.
Hormonal suppression can persist for weeks, needing recovery support.
Liver stress markers may take time to return to baseline.
Muscle retention issues may continue after withdrawal.
Full system balance may not return immediately after use.
Early reports may miss rare, delayed, or interaction-related harms. This section explains study observations only and does not justify anyone trying the substance. Individuals should stop and seek care for concerning symptoms and should not self-experiment.
Is YK-11 a Regulated Substance?
YK-11 is a regulated research chemical and not approved for medical or dietary use.
YK-11 is considered a research chemical and not approved for medical use. It is not legally sold as a dietary supplement in most countries. The World Anti-Doping Agency bans it in sports as part of the SARM category. Regulation is strict due to lack of safety data and misuse potential. It is available only in research contexts.
YK-11 is prohibited in competitive sports under the SARM category.
It is not approved for medical or supplement markets worldwide.
Its experimental status makes it available only as a research chemical.
Safety concerns drive its strict regulation outside laboratories.
Legal status, import rules, and anti-doping policies vary and change. Clinical study access does not imply personal use is permitted. Verify current rules with relevant authorities; do not proceed outside them.
When Was YK-11 First Used?
YK-11 was first described in scientific literature in 2011 as a synthetic SARM.
YK-11 was first described in scientific literature in 2011. It was synthesized as part of SARM development. Early studies explored its dual role in androgen receptor binding and myostatin inhibition. Unlike older SARMs, it stood out for targeting two muscle growth pathways. It has only been used in research since its creation.
First documented in 2011 as a novel SARM candidate.
Synthesized specifically to test selective anabolic activity.
Initial lab studies examined both muscle and bone effects.
Never approved for medical or supplement use, remaining experimental.
What Additional Research Is Needed on YK-11?
YK-11 needs more human studies to confirm safety, hormonal effects, and muscle-building potential.
YK-11 research needs basic safety studies before any clinical testing. Current knowledge is limited to early lab data and speculation. Long-term hormonal and liver effects are unknown. Studies must confirm whether its myostatin inhibition is reliable in humans. Until then, it remains highly experimental.
Toxicology studies are required to determine safe exposure limits.
Research should test its hormonal suppression in controlled trials.
Liver health impact must be assessed in both animals and humans.
Human clinical trials are absent and urgently needed for clarity.
Harald Ragnarok, Editor in Chief, Myopedia
Biohacking involves significant health risks, including potential disruption of normal body processes, interference with medications, and interactions with underlying medical conditions. The use of experimental substances—even when not currently banned or regulated—can have unpredictable and possibly long-term effects. Even where small human trials have reported encouraging short-term outcomes, the broader and long-term safety profiles often remain anecdotal or unverified. Myopedia recognizes the increasing attention toward biohacking and emerging longevity or performance technologies. These articles are intended to inform and encourage understanding of scientific developments, not to promote personal experimentation or unsupervised use.
Information about applications, case studies, or trial data is presented for educational purposes only, may contain inaccuracies or omissions, and should not be used to guide the use of any substance, method, or routine.